Ms. Nallicheri joined Foundation Medicine in October 2016 as chief business officer and head, Biopharma. She brings with her more than 25 years of experience in corporate strategy and business development, deep knowledge across healthcare sectors in the U.S. and internationally, as well as experience building advanced analytics capabilities. She has a track record of helping grow businesses and building high-performing teams.
Prior to joining Foundation Medicine, Ms. Nallicheri was senior vice president, corporate strategy and business development, McKesson Distribution Solutions and McKesson Data & Analytics. At McKesson, she was responsible for identifying growth opportunities and working closely with the executive committee and operating team to drive business growth, financial performance and strategy execution. During her tenure at McKesson, she advanced key strategic priorities, including evolving McKesson’s North American specialty, biosimilars and manufacturer services, pricing model and retail pharmacy strategy.
Before this, Ms. Nallicheri was senior vice president, corporate development at Geron Corporation where she was a member of the executive management team and responsible for corporate strategy and business development. Earlier in her career, she was a partner and senior member of the global health practice at Booz & Company/Booz Allen Hamilton.
She has held board positions at the American Red Cross Bay Area Chapter, Bay Area Council and Healthcare Business Women’s Association.
Ms. Nallicheri earned her MBA with honors from Columbia Business School, earning beta gamma sigma designation, and her MS in business and economics from WHU Otto Beisheim School of Corporate Management in Koblenz, Germany.